BluGlass Limited (ASX:BLG) Share Price Update – GaN Laser Development and Semiconductor Progress

Anjali Anand

05 August 2026 09:50 PM AEST

BluGlass Limited (ASX:BLG) Share Price Update – GaN Laser Development and Semiconductor Progress

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

BluGlass Limited (ASX:BLG) shares traded at $0.325, down $0.005 or 1.515% during the latest session.
The company recorded trading volume of 91,770 shares, with a market capitalisation of $62.70 million.
BluGlass secured a A$1.4 million Phase II contract with Uviquity under a Joint Development Agreement.
The company entered a A$1.3 million development agreement with a Fortune 500 global data storage company.
BluGlass achieved a world-record 1.9W peak output power from a single-mode blue gallium nitride (GaN) laser.

BluGlass Limited (ASX:BLG) operates in the semiconductor sector, developing visible gallium nitride (GaN) laser diode products for applications across industrial, defence, biomedical and scientific markets. The company provides custom laser development and manufacturing capabilities across epitaxy, device design, fabrication and testing from operations in Australia and the United States.

The company’s June 2026 quarter update highlighted commercial agreements, technology development milestones, customer engagements, capital raising activity and cash flow information for the three months ended 30 June 2026 (Q4 FY26).

Share Price Performance and Trading Activity

BluGlass Limited (ASX:BLG) shares traded at $0.325 during the latest session, declining by $0.005 or 1.515%. The stock recorded a daily trading range between $0.325 and $0.340, compared with the previous close of $0.330.

Trading volume was 91,770 shares, compared with an average volume of 627,217 shares. BluGlass has a 52-week trading range of $0.175 to $0.550, with 190,022,917 shares on issue.

Commercial Agreements Expand Development Pipeline

During the June 2026 quarter, BluGlass secured several customer-funded development opportunities. The company received a A$1.4 million (US$1 million) Phase II contract from Uviquity under an existing Joint Development Agreement. The agreement expands collaboration into engineering, novel packaging, laser integration and purchases of BluGlass visible GaN lasers.

BluGlass also entered a A$1.3 million development agreement with a global data storage company. Under the agreement, BluGlass will support next-generation photonics development activities using its visible GaN laser and semiconductor development capabilities. Payments are structured across four activity-based milestones expected to be completed over 12–18 months.

GaN Laser Technology Milestone

BluGlass achieved a world-record 1.9W of single-spatial mode power from its blue 450nm single-mode GaN laser during the quarter. This represented a 52% increase compared with the company’s previous record of 1.25W.

The milestone was achieved using BluGlass’ proprietary gain-chip technology incorporating a single-mode master oscillator with a tapered power amplifier (MOPA). The company stated that the technology is designed for applications requiring high optical power and beam quality across defence, aerospace, quantum and industrial markets.

Data Centre and AI Infrastructure Opportunity

BluGlass received an initial order from a strategic data centre customer developing optical interconnect technologies for future AI computing and data centre infrastructure.

The company noted that revenue from the initial purchase order was not material; however, the engagement may develop into a broader development program and potential long-term commercial relationship.

Capital Raising Strengthens Cash Position

BluGlass raised A$14.6 million during the quarter through an institutional placement, options exercise and shortfall agreement.

The company completed an upsized A$8 million placement at A$0.24 per share, supported by a A$2.3 million cornerstone investment from Board and management. Exercise of A$0.26 options contributed A$5.06 million, while A$1.5 million was received under a shortfall agreement with Amery Partners Pty Ltd.

Following the capital raising, BluGlass reported cash and cash equivalents of A$11.48 million at 30 June 2026.

Quarterly Cash Flow Update

BluGlass reported customer receipts of A$200,000 during the quarter, including the NCSU development contract and product laser orders. Research and development expenditure totalled A$3.01 million during Q4 FY26, covering salaries, materials and fabrication costs for laser product development.

The company recorded net cash used in operating activities of A$4.456 million for the quarter. Financing activities generated A$13.405 million, primarily from equity issuance and option exercises, resulting in a net increase in cash and cash equivalents during the period.

U.S. Defence and Photonics Engagements

During the quarter, BluGlass participated in defence and photonics industry engagements in the United States, including SPIE Defense + Security, a U.S. Navy industry gathering and a directed-energy technology roundtable.

The company stated that these engagements supported discussions with prospective customers, government stakeholders and industry partners regarding applications for visible GaN laser technology.

Looking Ahead

BluGlass is focused on progressing customer-funded development programs, converting opportunities from its project pipeline and expanding applications for its GaN laser technology. The company continues to develop relationships across photonics, defence, data centre and semiconductor applications. With cash and cash equivalents of A$11.48 million at 30 June 2026 following the A$14.6 million capital raising, BluGlass is continuing to fund commercialisation activities and product development initiatives.

Conclusion

BluGlass Limited (ASX:BLG) entered the second half of 2026 with new development agreements, technology milestones and additional funding following its June quarter activities update. The company’s progress remains centred on GaN laser development, customer-funded projects and applications across photonics, semiconductor and emerging technology markets.

FAQs

Q: What is the ASX code for BluGlass Limited?

A:BluGlass Limited trades on the Australian Securities Exchange under the code ASX:BLG.

Q: What was BluGlass’ latest share price?

A:BluGlass shares traded at $0.325 during the latest session, down $0.005 or 1.515%.

Q: What contract did BluGlass secure with Uviquity?

A:BluGlass secured a A$1.4 million Phase II contract from Uviquity under a Joint Development Agreement.

Q: How much capital did BluGlass raise during the June 2026 quarter?

A:BluGlass raised A$14.6 million through an institutional placement, options exercise and shortfall agreement.

Q: What technology does BluGlass develop?

A:BluGlass develops visible gallium nitride (GaN) laser diode products for industrial, defence, biomedical and scientific applications.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.